Teva stock surged early Wednesday after the drugmaker reported adjusted earnings of 78 cents per share on $4.48 billion in third-quarter sales. On average, analysts polled by FactSet expected Teva Pharmaceutical (TEVA) to earn 68 cents per share on$4.38 billion in sales. During the year-earlier period, Teva reported earnings of 69 cents per share and $4.33 billion in sales. Teva hiked its guidance for Austedo. The company now expects the movement disorders drug to bring in$2.05 billion to $2.15 billion in ...